The DOI matches its Crossref record; 121 of the 121 references it cites were found in a registry or an index.
TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Global Cancer Statistics, 2002
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,196
Nitric oxide: physiology, pathophysiology, and pharmacology.
Moncada, S., Palmer, R. M., & Higgs, E. A. (1991) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06663-3 · Cited by 15,525
The environment and disease: association or causation?
Hill, A. B. (2015) · Journal of the Royal Society of Medicine · doi:10.1177/0141076814562718 · Cited by 7,285
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Nitric oxide synthases: Roles, tolls, and controls
Nathan, C., & Xie, Q.-W. (1994) · Cell · doi:10.1016/0092-8674(94)90266-6 · Cited by 2,918
Rising Incidence of Hepatocellular Carcinoma in the United States
El-Serag, H. B., & Mason, A. C. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401001 · Cited by 2,853
NITRIC OXIDE: A Physiologic Messenger Molecule
Bredt, D. S., & Snyder, S. H. (1994) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.63.070194.001135 · Cited by 2,368
TIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis
Bensaad, K., Tsuruta, A., Selak, M. A., Vidal, M. N. C., Nakano, K., Bartrons, R., Gottlieb, E., & Vousden, K. H. (2006) · Cell · doi:10.1016/j.cell.2006.05.036 · Cited by 2,019 · cited 3×
“Moreover, we presented Table 4 Examples of anti-oxidant and -nitrosative activities of the p53 tumor suppressor Transcriptional transrepression of pro-oxidant enzymes Transcriptional transactivation of anti-oxidant enzymes NOS2 GPx (Tan et al., 1999) Human and mouse cells (Forrester et al., 1996) ALDH4 (Yoon et al., 2…”
BackgroundHepatocellular carcinoma pathogenesis: from genes to environment
Farazi, P. A., & DePinho, R. A. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1934 · Cited by 1,979
Cloning and Characterization of Inducible Nitric Oxide Synthase from Mouse Macrophages
Xie, Q.-W., Cho, H. J., Calaycay, J., Mumford, R. A., Swiderek, K. M., Lee, T. D., Ding, A., Troso, T., & Nathan, C. (1992) · Science · doi:10.1126/science.1373522 · Cited by 1,886
Hussain, S. P., Hofseth, L. J., & Harris, C. C. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1046 · Cited by 1,690 · cited 1×
“Chronic inflammation and infection is frequently associated with increased cancer risk, although exceptions can be cited, including rheumatoid arthritis and human papillomavirus infection (Table 3; Hussain et al., 2003).”
BackgroundSelf-citationEstimates of the worldwide mortality from 25 cancers in 1990
Pisani, P., Parkin, D. M., Bray, F., & Ferlay, J. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990924)83:1<18::aid-ijc5>3.0.co;2-m · Cited by 1,549
Mutational hot spot in the p53 gene in human hepatocellular carcinomas
Hsu, I. C., Metcalf, R. A., Sun, T., Welsh, J. A., Wang, N. J., & Harris, C. C. (1991) · Nature · doi:10.1038/350427a0 · Cited by 1,534
Self-citationMolecular pathogenesis of human hepatocellular carcinoma
Thorgeirsson, S. S., & Grisham, J. W. (2002) · Nature Genetics · doi:10.1038/ng0802-339 · Cited by 1,439
Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa
Bressac, B., Kew, M., Wands, J., & Ozturk, M. (1991) · Nature · doi:10.1038/350429a0 · Cited by 1,432
Nitric oxide synthase structure and mechanism
Marletta, M. A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31375-9 · Cited by 1,338
Hentze, M. W., & Kühn, L. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8175 · Cited by 1,292
The antioxidant function of the p53 tumor suppressor
Sablina, A. A., Budanov, A. V., Ilyinskaya, G. V., Agapova, L. S., Kravchenko, J. E., & Chumakov, P. M. (2005) · Nature Medicine · doi:10.1038/nm1320 · Cited by 1,121
Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2
Gupta, R. A., & DuBois, R. N. (2001) · Nature Reviews Cancer · doi:10.1038/35094017 · Cited by 1,066
Prostaglandin E 2 Promotes Colon Cancer Cell Growth Through a G s -Axin-ß-Catenin Signaling Axis
Castellone, M. D., Teramoto, H., Williams, B. O., Druey, K. M., & Gutkind, J. S. (2005) · Science · doi:10.1126/science.1116221 · Cited by 883
Ye, Q.-H., Qin, L.-X., Forgues, M., He, P., Kim, J. W., Peng, A. C., Simon, R., Li, Y., Robles, A. I., Chen, Y., et al. (2003) · Nature Medicine · doi:10.1038/nm843 · Cited by 850
Self-citationBudhu, A., Forgues, M., Ye, Q.-H., Jia, H.-L., He, P., Zanetti, K. A., Kammula, U. S., Chen, Y., Qin, L.-X., Tang, Z.-Y., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.06.016 · Cited by 846
Self-citationDNA Repair Helicase: a Component of BTF2 (TFIIH) Basic Transcription Factor
Schaeffer, L., Roy, R., Humbert, S., Moncollin, V., Vermeulen, W., Hoeijmakers, J. H. J., Chambon, P., & Egly, J.-M. (1993) · Science · doi:10.1126/science.8465201 · Cited by 794
Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma
Ross, R. K., Yu, M. C., Henderson, B. E., Yuan, J.-M., Qian, G.-S., Tu, J.-T., Gao, Y.-T., Wogan, G. N., & Groopman, J. D. (1992) · The Lancet · doi:10.1016/0140-6736(92)91528-g · Cited by 725
Qian, G.-S., Ross, R. K., Yu, M. C., Yuan, J., Gao, Y. T., Henderson, B. E., Wogan, G. N., & Groopman, J. D. (1994) · PubMed · Cited by 666
Wang, X. W., Forrester, K., Yeh, H., Feitelson, M. A., Gu, J. R., & Harris, C. C. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.6.2230 · Cited by 665
Self-citationp53: traffic cop at the crossroads of DNA repair and recombination
Sengupta, S., & Harris, C. C. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1546 · Cited by 544
Self-citationAguilar, F., Hussain, S. P., & Cerutti, P. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8586 · Cited by 489
Self-citationInducible Nitric Oxide Synthase Binds, S-Nitrosylates, and Activates Cyclooxygenase-2
Kim, S. F., Huri, D. A., & Snyder, S. H. (2005) · Science · doi:10.1126/science.1119407 · Cited by 489
Forrester, K., Ambs, S., Lupold, S. E., Kapust, R. B., Spillare, E. A., Weinberg, W. C., Felley-Bosco, E., Wang, X. W., Geller, D. A., Tzeng, E., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.6.2442 · Cited by 469
Self-citationNitric oxide synthase: expression and expressional control of the three isoforms
F�rstermann, U., & Kleinert, H. (1995) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/bf00172772 · Cited by 466
DI BISCEGLIE, A. M., RUSTGI, V. K., HOOFNAGLE, J. H., DUSHEIKO, G. M., & LOTZE, M. T. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-390 · Cited by 454
p53 mutation in hepatocellular carcinoma after aflatoxin exposure
Bressac, B., Puisieux, A., Kew, M., Volkmann, M., Bozcall, S., Bella Mura, J., de la Monte, S., Carlson, R., Blum, H., Wands, J., et al. (1991) · The Lancet · doi:10.1016/0140-6736(91)92236-u · Cited by 449
Environmental factors and risk for hepatocellular carcinoma
Yu, M. C., & Yuan, J.-M. (2004) · Gastroenterology · doi:10.1016/j.gastro.2004.09.018 · Cited by 426
Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin
Nussler, A. K., Di Silvio, M., Billiar, T. R., Hoffman, R. A., Geller, D. A., Selby, R., Madariaga, J., & Simmons, R. L. (1992) · The Journal of Experimental Medicine · doi:10.1084/jem.176.1.261 · Cited by 420
Hussain, S. P., & Harris, C. C. (1998) · PubMed · Cited by 407
Self-citationde Vera, M. E., Shapiro, R. A., Nussler, A. K., Mudgett, J. S., Simmons, R. L., Morris, S. M., Billiar, T. R., & Geller, D. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.3.1054 · Cited by 399
Iron, hemochromatosis, and hepatocellular carcinoma
Kowdley, K. V. (2004) · Gastroenterology · doi:10.1016/j.gastro.2004.09.019 · Cited by 391
p53-Induced Up-Regulation of MnSOD and GPx but not Catalase Increases Oxidative Stress and Apoptosis
Hussain, S. P., Amstad, P., He, P., Robles, A., Lupold, S., Kaneko, I., Ichimiya, M., Sengupta, S., Mechanic, L., Okamura, S., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-2287-2 · Cited by 384
Self-citationFunctional inactivation but not structural mutation of p53 causes liver cancer
Ueda, H., Ullrich, S. J., Gangemi, J. D., Kappel, C. A., Ngo, L., Feitelson, M. A., & Jay, G. (1995) · Nature Genetics · doi:10.1038/ng0195-41 · Cited by 367
Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis
Elmore, L. W., Hancock, A. R., Chang, S.-F., Wang, X. W., Chang, S., Callahan, C. P., Geller, D. A., Will, H., & Harris, C. C. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14707 · Cited by 333
Self-citationRegulation of cyclooxygenase-2 expression by the Wnt and ras pathways.
Araki, Y., Okamura, S., Hussain, S. P., Nagashima, M., He, P., Shiseki, M., Miura, K., & Harris, C. C. (2003) · PubMed · Cited by 322
Self-citationHepatitis B virus X protein: a multifunctional viral regulator
Murakami, S. (2001) · Journal of Gastroenterology · doi:10.1007/s005350170027 · Cited by 322
Abrogation of p53-Induced Apoptosis by the Hepatitis B Virus X Gene
Wang, X. W. (2003) · Hepatocellular Carcinoma · doi:10.1385/1-59259-079-9:57 · Cited by 321
Self-citationFeitelson, M. A., Zhu, M., Duan, L., & London, W. T. (1993) · PubMed · Cited by 307
Synergistic interaction between aflatoxin B1 and hepatitis B virus in hepatocarcinogenesis
Kew, M. C. (2003) · Liver International · doi:10.1111/j.1478-3231.2003.00869.x · Cited by 302
Nitric oxide-induced apoptosis: p53-dependent and p53-independent signalling pathways
MESSMER, U. K., & BRÜNE, B. (1996) · Biochemical Journal · doi:10.1042/bj3190299 · Cited by 287
Molecular functions and biological roles of hepatitis B virus x protein
Tang, H., Oishi, N., Kaneko, S., & Murakami, S. (2006) · Cancer Science · doi:10.1111/j.1349-7006.2006.00299.x · Cited by 282
Geographic Variation of p53 Mutational Profile in Nonmalignant Human Liver
Aguilar, F., Harris, C. C., Sun, T., Hollstein, M., & Cerutti, P. (1994) · Science · doi:10.1126/science.8191284 · Cited by 282
Self-citationHepatitis B Virus X Protein Interferes with Cellular DNA Repair
Becker, S. A., Lee, T.-H., Butel, J. S., & Slagle, B. L. (1998) · Journal of Virology · doi:10.1128/jvi.72.1.266-272.1998 · Cited by 276
Induction of tumor necrosis factor alpha production by human hepatocytes in chronic viral hepatitis.
González-Amaro, R., García-Monzón, C., García-Buey, L., Moreno-Otero, R., Alonso, J. L., Yagüe, E., Pivel, J. P., López-Cabrera, M., Fernández-Ruiz, E., & Sánchez-Madrid, F. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.3.841 · Cited by 260
Transcriptional Activation of the Human Glutathione Peroxidase Promoter by p53
Tan, M., Li, S., Swaroop, M., Guan, K., Oberley, L. W., & Sun, Y. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.17.12061 · Cited by 253
p53 gene mutation spectrum in hepatocellular carcinoma.
Oda, T., Tsuda, H., Scarpa, A., Sakamoto, M., & Hirohashi, S. (1992) · PubMed · Cited by 250
Molecular pathogenesis of human hepatocellular carcinoma
Wang, X. W., Hussain, S. P., Huo, T.-I., Wu, C.-G., Forgues, M., Hofseth, L. J., Brechot, C., & Harris, C. C. (2002) · Toxicology · doi:10.1016/s0300-483x(02)00253-6 · Cited by 246
Self-citationTP53 mutation spectra and load: a tool for generating hypotheses on the etiology of cancer.
Olivier, M., Hussain, S. P., de Fromentel, C. C., Hainaut, P. L., & Harris, C. C. (2004) · PubMed · Cited by 243
Self-citationStaib, F., Perwez Hussain, S., Hofseth, L. J., Wang, X. W., & Harris, C. C. (2003) · Human Mutation · doi:10.1002/humu.10176 · Cited by 241
Self-citationIdentification of ALDH4 as a p53-inducible gene and its protective role in cellular stresses
Yoon, K.-A., Nakamura, Y., & Arakawa, H. (2004) · Journal of Human Genetics · doi:10.1007/s10038-003-0122-3 · Cited by 234
Ambs, S., Hussain, S. P., & Harris, C. C. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.6.9194524 · Cited by 233
Self-citationMing, L., Thorgeirsson, S. S., Gail, M. H., Lu, P., Harris, C. C., Wang, N., Shao, Y., Wu, Z., Liu, G., Wang, X., et al. (2002) · Hepatology · doi:10.1053/jhep.2002.36366 · Cited by 233
Self-citationMace, K. (1997) · Carcinogenesis · doi:10.1093/carcin/18.7.1291 · Cited by 224
The role of nitric oxide (NO·) in the carcinogenic process
Tamir, S., & Tannenbaum, S. R. (1996) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(96)00021-2 · Cited by 221
Sirma, H., Giannini, C., Poussin, K., Paterlini, P., Kremsdorf, D., & Bréchot, C. (1999) · Oncogene · doi:10.1038/sj.onc.1202867 · Cited by 207
Arbuthnot, P., Capovilla, A., & Kew, M. (2000) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2000.02069.x · Cited by 198
Ser-249 p53 Mutations in Plasma DNA of Patients With Hepatocellular Carcinoma From The Gambia
Kirk, G. D., Camus-Randon, A.-M., Mendy, M., Goedert, J. J., Merle, P., Trépo, C., Bréchot, C., Hainaut, P., & Montesano, R. (2000) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/92.2.148 · Cited by 190
Tu, H., Bonura, C., Giannini, C., Mouly, H., Soussan, P., Kew, M. C., Paterlini-Bréchot, P., Bréchot, C., & Kremsdorf, D. (2001) · PubMed · Cited by 185
Kirk, G. D., Lesi, O. A., Mendy, M., Szymañska, K., Whittle, H., Goedert, J. J., Hainaut, P., & Montesano, R. (2005) · Oncogene · doi:10.1038/sj.onc.1208732 · Cited by 181
Kondo, M., Yamamoto, H., Nagano, H., Okami, J., Ito, Y., Shimizu, J., Eguchi, H., Miyamoto, A., Dono, K., Umeshita, K., et al. (1999) · PubMed · Cited by 176
Progressive telomere shortening and telomerase reactivation during hepatocellular carcinogenesis
Miura, N., Horikawa, I., Nishimoto, A., Ohmura, H., Ito, H., Hirohashi, S., Shay, J. W., & Oshimura, M. (1997) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(96)00329-9 · Cited by 174 · cited 1×
“Moreover, HBx deregulates cell cycle check point controls and blocks p53-mediated apoptosis (Lucito and Schneider, 1992; Feitelson et al., 1993; Bennett et al., 1995; Wang et al., 1995; Miura et al., 1997; Chan and Ng, 2006).”
BackgroundUp-regulation of inducible nitric oxide synthase expression in cancer-prone p53 knockout mice
Ambs, S., Ogunfusika, M. O., Merriam, W. G., Bennett, W. P., Billiar, T. R., & Harris, C. C. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8823 · Cited by 171
Self-citationLunn, R. M., Zhang, Y. J., Wang, L., Chen, C., Lee, P., Lee, C. S., Tsai, W. Y., & Santella, R. M. (1997) · PubMed · Cited by 170
Ambs, S., & Harris, C. C. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.17.1510 · Cited by 170
Self-citationHepatitis B virus X protein inhibits nucleotide excision repair
Jia, L., Wang, X. W., & Harris, C. C. (1999) · International Journal of Cancer · Cited by 169
Self-citationAmbs, S., Bennett, W. P., Merriam, W. G., Ogunfusika, M. O., Oser, S. M., Harrington, A. M., Shields, P. G., Felley-Bosco, E., Hussain, S. P., & Harris, C. C. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.1.86 · Cited by 166
Self-citationFukutomi, T., Zhou, Y., Kawai, S., Eguchi, H., Wands, J. R., & Li, J. (2005) · Hepatology · doi:10.1002/hep.20668 · Cited by 166
Specific mutations of hepatitis B virus in plasma predict liver cancer development
Kuang, S.-Y., Jackson, P. E., Wang, J.-B., Lu, P.-X., Muñoz, A., Qian, G.-S., Kensler, T. W., & Groopman, J. D. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308232100 · Cited by 165
Insights into the Pathobiology of Hepatitis C Virus-Associated Cirrhosis
Shackel, N. A., McGuinness, P. H., Abbott, C. A., Gorrell, M. D., & McCaughan, G. W. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64884-5 · Cited by 162
Scorsone, K. A., Zhou, Y. Z., Butel, J. S., & Slagle, B. L. (1992) · PubMed · Cited by 162
Genetic heterogeneity of hepatocellular carcinoma.
Unsal, H., Yakicier, C., Marçais, C., Kew, M., Volkmann, M., Zentgraf, H., Isselbacher, K. J., & Ozturk, M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.2.822 · Cited by 161
Differential gene expression between chronic hepatitis B and C hepatic lesion
Honda, M., Kaneko, S., Kawai, H., Shirota, Y., & Kobayashi, K. (2001) · Gastroenterology · doi:10.1053/gast.2001.22468 · Cited by 161
Bennett, M. R., Evan, G. I., & Schwartz, S. M. (1995) · Circulation Research · doi:10.1161/01.res.77.2.266 · Cited by 152
Majano, P. L., García‐Monzón, C., López‐Cabrera, M., Lara‐Pezzi, E., Fernández‐Ruiz, E., García-Iglesias, C., Borque, M. J., & Moreno‐Otero, R. (1998) · Journal of Clinical Investigation · doi:10.1172/jci774 · Cited by 151
Guengerich, F. P., Johnson, W. W., Ueng, Y., Yamazaki, H., & Shimada, T. (1996) · Environmental Health Perspectives · doi:10.1289/ehp.96104s3557 · Cited by 142
Qadri, I., Conaway, J. W., Conaway, R. C., Schaack, J. B., & Siddiqui, A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.10578 · Cited by 138
Transcriptional repression of the human p53 gene by hepatitis B viral X protein
Lee, S., & Rho, H. M. (2000) · Oncogene · doi:10.1038/sj.onc.1203312 · Cited by 127
Ambs, S., Bennett, W. P., Merriam, W. G., Ogunfusika, M. O., Oser, S. M., Khan, M. H., Jones, R., & Harris, C. C. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.470 · Cited by 124
Self-citationComparative and integrative functional genomics of HCC
Lee, J.-S., & Thorgeirsson, S. S. (2006) · Oncogene · doi:10.1038/sj.onc.1209561 · Cited by 121
Nijmegen Breakage Syndrome disease protein and Mre11 at PML Nuclear Bodies and meiotic telomeres
Lombard, D. B. (2001) · Springer eBooks · doi:10.1007/978-1-4615-1405-3_4 · Cited by 120
Connecting COX-2 and Wnt in cancer
Buchanan, F. G., & DuBois, R. N. (2006) · Cancer Cell · doi:10.1016/j.ccr.2005.12.029 · Cited by 120
Farazi, P. A., Glickman, J. N., Horner, J. W., & DePinho, R. A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4608 · Cited by 119
Regulation of Human Nitric Oxide Synthase 2 Expression by Wnt β-Catenin Signaling
Du, Q., Park, K. S., Guo, Z., He, P., Nagashima, M., Shao, L., Sahai, R., Geller, D. A., & Hussain, S. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4110 · Cited by 109
Self-citationDevereux, T. R., Stern, M. C., Flake, G. P., Yu, M. C., Zhang, Z., London, S. J., & Taylor, J. A. (2001) · Molecular Carcinogenesis · doi:10.1002/mc.1041 · Cited by 103
Staib, F., Robles, A. I., Varticovski, L., Wang, X. W., Zeebèrg, B. R., Sirotin, M., Zhurkin, V. B., Hofseth, L. J., Hussain, S. P., Weinstein, J. N., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1714 · Cited by 103
Self-citationHuo, T., Wang, X. W., Forgues, M., Wu, C.-G., Spillare, E. A., Giannini, C., Bréchot, C., & Harris, C. C. (2001) · Oncogene · doi:10.1038/sj.onc.1204495 · Cited by 102
Self-citationEffects of p53 mutants on wild-type p53-mediated transactivation are cell type dependent.
Forrester, K., Lupold, S. E., Ott, V. L., Chay, C. H., Band, V., Wang, X. W., & Harris, C. C. (1995) · PubMed · Cited by 100
Self-citationHepatocellular Carcinoma: An Update
Domínguez-Malagón, H. R., & Gaytan-Graham, S. (2001) · Ultrastructural Pathology · doi:10.1080/019131201753343539 · Cited by 99
Ponchel, F., Puisieux, A., Tabone, É., Michot, J., Fröschl, G., Morel, A., Frébourg, T., Fontanière, B., Oberhammer, F., & Öztürk, M. (1994) · PubMed · Cited by 95
Hussain, S. P., Hofseth, L. J., & Harris, C. C. (2001) · Lung Cancer · doi:10.1016/s0169-5002(01)00339-7 · Cited by 89
Self-citationp53 Mutations in human hepatocellular carcinomas from Germany.
Kress, S., Jahn, U.-R., Buchmann, A., Bannasch, P., & Schwarz, M. (1992) · PubMed · Cited by 88
Marrogi, A. J., Ma, K., van Gijssel, H. E., Welsh, J. A., Rahim, H., Demetris, A. J., Kowdley, K. V., Hussain, S. P., Nair, J. R., Bartsch, H., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.21.1652 · Cited by 85
Self-citationYoram Vodovotz, B., Kim, P., Bagci, E. Z., Ermentrout, B., Chow, C. C., Bahar, İ., & Billiar, T. R. (2004) · Current Molecular Medicine · doi:10.2174/1566524043359944 · Cited by 79
Madden, C. R., Finegold, M. J., & Slagle, B. L. (2002) · Journal of Virology · doi:10.1128/jvi.76.22.11770-11774.2002 · Cited by 73
Mutagenesis of the H-ras protooncogene and the p53 tumor suppressor gene.
Cerutti, P., Hussain, S. P., Pourzand, C., & Aguilar, F. (1994) · PubMed · Cited by 69
Self-citationLow frequency of p53 gene mutation in tumors induced by aflatoxin B1 in nonhuman primates.
Fujimoto, Y., Hampton, L. L., Luo, L., Wirth, P. J., & Thorgeirsson, S. S. (1992) · PubMed · Cited by 67
Kane, J. M., Shears, L. L., Hierholzer, C., Ambs, S., Billiar, T. R., & Posner, M. C. (1997) · Journal of Surgical Research · doi:10.1006/jsre.1997.5057 · Cited by 65
Linear dose-response relationship for DNA adducts in rat liver from chronic exposure to aflatoxin B1
Buss, P., Caviezel, M., & Lutz, W. K. (1990) · Carcinogenesis · doi:10.1093/carcin/11.12.2133 · Cited by 62
Kuang, S.-Y., Lekawanvijit, S., Maneekarn, N., et al. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0380 · Cited by 59
p53-mediated cellular response to DNA damage in cells with replicative hepatitis B virus.
Puisieux, A., Ji, J., Guillot, C., Legros, Y., Soussi, T., Isselbacher, K. J., & Öztürk, M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.5.1342 · Cited by 57
Gastrointestinal Oncology: Principles and Practice
Croghan, G. A. (2002) · Mayo Clinic Proceedings · doi:10.4065/77.10.1138-c · Cited by 55
Fujimoto, H., Sasaki, J.-I., Matsumoto, M., Suga, M., Ando, Y., Iggo, R. D., Tada, M., Saya, H., & Ando, M. (1998) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1998.tb03273.x · Cited by 54
Chan, D. W., & Ng, I. O. (2005) · The Journal of Pathology · doi:10.1002/path.1901 · Cited by 52
Dumenco, L. L., Oguey, D., Wu, J. C., Messier, N. J., & Fausto, N. (1995) · Hepatology · doi:10.1016/0270-9139(95)90640-1 · Cited by 51
The Molecular Signature of Metastases of Human Hepatocellular Carcinoma
Budhu, A., Zipser, B. D., Forgues, M., Ye, Q., Sun, Z., & Wang, X. W. (2005) · Oncology · doi:10.1159/000086628 · Cited by 50
Self-citationMechanisms of carcinogenesis : contributions of molecular epidemiology
Buffler, P. A. (2004) · International Agency for Research on Cancer eBooks · Cited by 47
Mathonnet, G., Lachance, S., Alaoui‐Jamali, M. A., & Drobetsky, E. A. (2004) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2004.05.010 · Cited by 44
Gastrointestinal Oncology: Principles and Practice
Kelsen, D. P. (2001) · Medical Entomology and Zoology · Cited by 41
Molecular mechanisms underlying the development of hepatocellular carcinoma
Bergsland, E. K. (2001) · Seminars in Oncology · doi:10.1016/s0093-7754(01)90145-9 · Cited by 41
Gene expression profile linked to p53 status in hepatitis C virus‐related hepatocellular carcinoma
Okada, T., Iizuka, N., Yamada‐Okabe, H., Mori, N., Tamesa, T., Takemoto, N., Tangoku, A., Hamada, K., Nakayama, H., Miyamoto, T., et al. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)01345-0 · Cited by 37
Hepatitis B Virus X Protein Transactivates the Inducible Nitric Oxide Synthase Promoter
Amaro, M. J., Bartolomé, J., & Carréño, V. (1999) · Hepatology · doi:10.1002/hep.510290337 · Cited by 37
Tong, W., Lee, M., Galendo, D., Wang, Z., & Sabapathy, K. (2006) · International Journal of Cancer · doi:10.1002/ijc.21890 · Cited by 32
Jia, L., Wang, X. W., Sun, Z., & Harris, C. C. (1997) · Springer eBooks · doi:10.1007/978-4-431-65915-0_15 · Cited by 5
Self-citation
Cited by
TP53 mutations in human cancers: origins, consequences, and clinical use.
Olivier, M., Hollstein, M., & Hainaut, P. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001008 · Cited by 2,199
Molecular targeted therapies in hepatocellular carcinoma†
Llovet, J. M., & Bruix, J. (2008) · Hepatology · doi:10.1002/hep.22506 · Cited by 1,004
Mycotoxins and human disease: a largely ignored global health issue
Wild, C. P., & Gong, Y. Y. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp264 · Cited by 981
TP53 mutations in human cancers: Functional selection and impact on cancer prognosis and outcomes
Petitjean, A., Achatz, M. I. W., Borresen-Dale, A. L., Hainaut, P., & Olivier, M. (2007) · Oncogene · doi:10.1038/sj.onc.1210302 · Cited by 884
Li-Weber, M. (2009) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2008.09.005 · Cited by 896
Metadata
- Authors
- Hussain, S. P., Schwank, J., Staib, F., Wang, X. W., & Harris, C. C.
- Venue
- Oncogene
- Published
- 2007-04-02
- Volume
- 26
- Issue
- 15
- Pages
- 2166-2176
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2042753075
- Cited by
- 621
- References
- 121
- FWCI
- 16.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.